CCND1 and familial pancreatic carcinoma: In addition, a study previously reported the reduction of cyclin D1 expression following therapy of pancreatic cancer cells with nonsteroidal anti‐inflammatory drugs such as sulindac, which suppress cell cycle progression [108].